Deutsche Bank
ATNM icon

Deutsche Bank’s Actinium Pharmaceuticals ATNM Stock Holding History

Deutsche Bank’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-123,134
Closed -$198K – 3614
2025
Q1 		$198K Hold
123,134
– – ﹤0.01% 2950
2024
Q4 		$155K Buy
123,134
+99,158
+414% +$154K ﹤0.01% 3168
2024
Q3 		$45.1K Buy
23,976
+5,863
+32% +$23.2K ﹤0.01% 3384
2024
Q2 		$134K Buy
18,113
+4,557
+34% +$37.5K ﹤0.01% 3015
2024
Q1 		$106K Sell
13,556
-622
-4% -$4K ﹤0.01% 3141
2023
Q4 		$72K Sell
14,178
-1,057
-7% -$5.44K ﹤0.01% 3350
2023
Q3 		$90.2K Buy
15,235
+13,265
+673% +$88.3K ﹤0.01% 3204
2023
Q2 		$14.6K Buy
+1,970
New +$16.8K ﹤0.01% 3615
2021
Q1 		– Sell
-26,166
Closed -$204K – 4534
2020
Q4 		$204K Sell
26,166
-21,433
-45% -$233K ﹤0.01% 3454
2020
Q3 		$461K Buy
+47,599
New +$525K ﹤0.01% 2681
2019
Q2 		– Sell
-1,983
Closed -$28K – 5276
2019
Q1 		$28K Buy
1,983
+1,971
+16,425% +$31.5K ﹤0.01% 4721
2018
Q4 		$0 Sell
12
-42
-78% -$716 ﹤0.01% 5149
2018
Q3 		$1K Sell
54
-3,053
-98% -$62.1K ﹤0.01% 5272
2018
Q2 		$60K Buy
3,107
+2,994
+2,650% +$37.9K ﹤0.01% 4715
2018
Q1 		$1K Buy
+113
New +$1.92K ﹤0.01% 5328
2016
Q3 		– Sell
-3
Closed – – 4899
2016
Q2 		$0 Sell
3
-568
-99% -$31.7K ﹤0.01% 5164
2016
Q1 		$33K Buy
571
+535
+1,486% +$33.8K ﹤0.01% 4460
2015
Q4 		$3K Sell
36
-996
-97% -$66.2K ﹤0.01% 5108
2015
Q3 		$54K Buy
1,032
+961
+1,354% +$64.2K ﹤0.01% 4409
2015
Q2 		$5K Sell
71
-1,209
-94% -$103K ﹤0.01% 5142
2015
Q1 		$94K Buy
+1,280
New +$152K ﹤0.01% 4144
2014
Q4 		– Sell
-8
Closed -$1.52K – 6137
2014
Q3 		$1K Buy
8
+5
+167% +$992 ﹤0.01% 5729
2014
Q2 		$0 Buy
+3
New +$999 ﹤0.01% 5874

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Deutsche Bank's ATNM Position: Q2 2025 in Review

Deutsche Bank sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 123,134 shares — an estimated $198K sold.

Deutsche Bank first reported a position in ATNM in Q2 2014 and held it in 23 quarters. The position peaked at $461K in Q3 2020. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.

  • Deutsche Bank reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 123,134 Actinium Pharmaceuticals shares in Q2 2025, an estimated $198K.
  • Deutsche Bank first reported a position in Actinium Pharmaceuticals in Q2 2014 and held it in 23 quarters.
  • Deutsche Bank's Actinium Pharmaceuticals position peaked at $461K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.